Christopher J. Kochansky
Exelixis (United States)(US)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Peptidase Inhibition and Analysis, Drug Transport and Resistance Mechanisms, Mass Spectrometry Techniques and Applications, Innovative Microfluidic and Catalytic Techniques Innovation
Most-Cited Works
- → Impact of pH on Plasma Protein Binding in Equilibrium Dialysis(2008)86 cited
- → Disposition of the Dipeptidyl Peptidase 4 Inhibitor Sitagliptin in Rats and Dogs(2007)59 cited
- → Determination of uremic toxins in biofluids: creatinine, creatine, uric acid and xanthines(2000)49 cited
- → Endosomolytic Bioreducible Poly(amido amine disulfide) Polymer Conjugates for the in Vivo Systemic Delivery of siRNA Therapeutics(2013)39 cited
- → DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS(2004)38 cited
- → Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability(2006)37 cited
- → 8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors(2007)37 cited
- → Increasing the Efficiency of In-Capillary Electrophoretically Mediated Microanalysis Reactions via Rapid Polarity Switching(2005)28 cited
- → METABOLISM AND PHARMACOKINETICS OF A DIPEPTIDYL PEPTIDASE IV INHIBITOR IN RATS, DOGS, AND MONKEYS WITH SELECTIVE CARBAMOYL GLUCURONIDATION OF THE PRIMARY AMINE IN DOGS(2003)22 cited
- → 10-Hydroxy-7,8-dihydropyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones: Potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants(2008)20 cited